[1]
Gruden, M.A. and Sherstnev, V.V. 2022. Neuroimmune biomarkers as molecular indicators of the development of prehypertension and hypertension. Patogenez (Pathogenesis). 20, 3 (Oct. 2022), 83-84. DOI:https://doi.org/10.25557/2310-0435.2022.03.83-84.